Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$33
Sep-14-20 Initiated
Morgan Stanley
Overweight
$24
Jul-15-20 Upgrade
Cleveland Research
Neutral → Buy
Jan-08-20 Initiated
Wells Fargo
Overweight
$22
Jan-07-20 Initiated
Citigroup
Buy
$21
Nov-15-19 Initiated
Stifel
Hold
Aug-02-19 Initiated
Cleveland Research
Neutral
Jun-14-19 Initiated
Janney
Buy
$27
Jun-12-19 Initiated
Raymond James
Outperform
$20
Jun-11-19 Initiated
William Blair
Outperform
Jun-11-19 Initiated
UBS
Buy
$21
Jun-11-19 Initiated
SunTrust
Buy
$22
Jun-11-19 Initiated
Robert W. Baird
Outperform
$20
Jun-11-19 Initiated
RBC Capital Mkts
Outperform
$22
Jun-11-19 Initiated
Piper Jaffray
Neutral
Jun-11-19 Initiated
KeyBanc Capital Markets
Sector Weight
Jun-11-19 Initiated
JP Morgan
Overweight
$20
Jun-11-19 Initiated
Jefferies
Buy
Jun-11-19 Initiated
Guggenheim
Buy
$21
Jun-11-19 Initiated
Goldman
Buy
$20
Feb-26-21 06:26PM
Feb-23-21 04:56PM
Feb-22-21 06:03PM
Feb-10-21 08:37AM
Feb-03-21 09:00PM
06:05PM
05:03PM
04:05PM
03:15PM
07:12AM
Feb-02-21 08:37AM
Jan-29-21 12:00PM
Jan-28-21 12:10PM
12:00PM
Jan-27-21 07:00AM
Jan-21-21 04:05PM
Jan-13-21 11:30PM
Jan-11-21 04:05PM
06:01AM
Dec-17-20 08:37AM
Dec-16-20 08:42AM
Dec-15-20 08:04AM
Dec-14-20 08:37AM
08:02AM
Dec-07-20 08:48AM
Nov-26-20 11:51PM
Nov-23-20 08:37AM
Nov-19-20 08:37AM
Nov-16-20 04:27AM
Nov-11-20 08:37AM
Nov-09-20 12:34PM
08:36AM
Nov-05-20 10:07PM
Nov-04-20 04:05PM
Nov-03-20 09:41AM
Nov-02-20 08:37AM
Oct-30-20 04:05PM
Oct-29-20 01:30AM
Oct-28-20 03:00PM
01:28PM
07:37AM
Oct-27-20 04:05PM
11:08AM
Oct-23-20 08:01AM
Oct-21-20 04:05PM
Oct-08-20 08:37AM
Oct-06-20 10:16AM
Oct-02-20 09:05AM
Sep-28-20 06:48AM
Sep-22-20 09:05AM
Sep-11-20 01:05PM
Sep-01-20 08:05AM
Aug-31-20 09:25AM
Aug-24-20 08:49AM
Aug-20-20 08:31AM
Aug-19-20 04:14PM
Aug-10-20 08:01AM
Jul-30-20 09:38AM
09:02AM
Jul-29-20 05:55PM
05:00PM
Jul-28-20 09:23AM
Jul-22-20 12:32PM
Jul-21-20 04:05PM
Jul-15-20 12:10PM
Jul-12-20 12:33PM
Jul-07-20 04:15PM
03:50AM
03:45AM
Jul-01-20 04:05PM
Jun-30-20 08:25AM
Jun-23-20 08:25AM
Jun-08-20 01:57AM
May-29-20 01:13PM
May-26-20 04:05PM
11:11AM
08:58AM
May-22-20 10:40AM
May-20-20 10:33PM
May-18-20 04:05PM
May-15-20 09:53AM
May-06-20 09:01AM
Apr-30-20 10:44PM
10:30AM
Apr-29-20 04:05PM
Apr-28-20 12:42PM
Apr-23-20 09:54AM
Apr-21-20 04:05PM
Apr-03-20 04:10PM
Mar-23-20 11:10AM
06:00AM
Mar-18-20 08:37AM
Mar-04-20 01:15PM
Feb-18-20 04:05PM
Feb-14-20 12:32PM
Feb-10-20 09:50AM
Feb-07-20 06:00AM
Jan-30-20 04:30PM
Jan-24-20 04:23PM
Jan-21-20 04:05PM
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Eck Steven W SVP & Chief Accounting Officer Feb 24 Option Exercise 0.00 8,550 0 28,532 Feb 26 06:44 PM Brophy Gerard EVP, Biopharma Production Feb 24 Sale 27.93 3,059 85,438 172,384 Feb 26 06:34 PM Brophy Gerard EVP, Biopharma Production Feb 22 Option Exercise 17.67 19,769 349,318 195,212 Feb 23 05:51 PM Brophy Gerard EVP, Biopharma Production Feb 22 Sale 28.62 19,769 565,789 175,443 Feb 23 05:51 PM Wondrasch Michael EVP & CIO Feb 05 Option Exercise 23.20 40,000 928,000 181,543 Feb 08 06:23 PM Wondrasch Michael EVP & CIO Feb 05 Sale 29.77 49,468 1,472,662 141,543 Feb 08 06:23 PM Brophy Gerard EVP, Biopharma Production Jan 11 Option Exercise 23.20 378,580 8,783,056 394,847 Jan 13 05:41 PM Bramwell James EVP, Strategic Partners Jan 11 Sale 30.00 2,505 75,150 116,430 Jan 13 05:43 PM Brophy Gerard EVP, Biopharma Production Jan 11 Sale 30.06 378,580 11,381,196 178,515 Jan 13 05:41 PM Brophy Gerard EVP, Biopharma Production Jan 06 Sale 27.24 11,509 313,505 178,515 Jan 08 07:31 PM Brophy Gerard EVP, Biopharma Production Jan 04 Option Exercise 18.45 59,418 1,096,262 249,442 Jan 06 09:06 PM Brophy Gerard EVP, Biopharma Production Jan 04 Sale 27.84 59,418 1,654,197 190,024 Jan 06 09:06 PM Bramwell James EVP, Strategic Partners Dec 21 Sale 27.14 10,020 271,943 117,768 Dec 23 05:10 PM Shaw Christi Director Dec 11 Sale 26.68 14,286 381,150 11,319 Dec 15 07:16 PM Stubblefield Michael President and CEO Dec 07 Option Exercise 1.60 210,369 336,590 1,945,717 Dec 08 07:09 PM Stubblefield Michael President and CEO Dec 07 Sale 27.45 98,452 2,702,507 1,847,265 Dec 08 07:09 PM Stubblefield Michael President and CEO Dec 04 Option Exercise 1.60 880,601 1,408,962 2,147,536 Dec 08 07:09 PM Stubblefield Michael President and CEO Dec 04 Sale 27.08 412,188 11,162,051 1,735,348 Dec 08 07:09 PM New Mountain Investments III, 10% Owner Nov 10 Sale 24.81 36,016,093 893,490,837 28,000,000 Nov 10 09:24 PM Ohri Devashish EVP, IMEA Oct 05 Option Exercise 1.60 103,440 165,504 201,671 Oct 07 08:23 PM Ohri Devashish EVP, IMEA Oct 05 Sale 23.42 103,440 2,422,343 151,671 Oct 07 08:23 PM Ohri Devashish EVP, IMEA Sep 16 Option Exercise 1.60 35,000 56,000 186,671 Sep 17 04:39 PM Ohri Devashish EVP, IMEA Sep 16 Sale 23.02 35,000 805,700 151,671 Sep 17 04:39 PM Miller Justin EVP & General Counsel Sep 08 Sale 21.17 22,887 484,518 113,507 Sep 09 04:43 PM Natauri Jo Director Aug 21 Sale 19.51 15,397,005 300,341,678 43,483,708 Aug 25 08:46 PM GOLDMAN SACHS & CO. LLC 10% Owner Aug 21 Sale 19.51 15,397,005 300,341,678 43,483,708 Aug 25 08:40 PM New Mountain Investments III, 10% Owner Aug 21 Sale 19.51 25,575,472 498,887,945 64,016,093 Aug 25 05:08 PM GUPTA RAJIV Director Aug 19 Option Exercise 1.60 1,147,970 1,836,752 1,856,716 Aug 19 02:06 PM Ohri Devashish EVP, IMEA Jul 30 Option Exercise 1.60 35,000 56,000 186,671 Aug 03 05:45 PM Ohri Devashish EVP, IMEA Jul 30 Sale 21.37 35,000 747,950 151,671 Aug 03 05:45 PM Ohri Devashish EVP, IMEA May 29 Option Exercise 1.60 65,000 104,000 186,671 Jun 02 05:50 PM Ohri Devashish EVP, IMEA May 29 Sale 18.84 65,000 1,224,550 151,671 Jun 02 05:50 PM New Mountain Investments III, 10% Owner May 26 Sale 15.90 20,886,424 332,192,308 89,591,565 May 28 06:01 PM Natauri Jo Director May 26 Sale 15.90 13,726,411 218,249,935 58,881,710 May 28 05:35 PM Connolly Thomas Director May 26 Sale 15.90 13,726,411 218,249,935 58,881,710 May 28 05:31 PM GOLDMAN SACHS & CO. LLC 10% Owner May 26 Sale 15.90 13,726,411 218,249,935 58,881,710 May 28 05:26 PM Wondrasch Michael EVP & CIO May 22 Sale 17.82 22,987 409,628 154,087 May 27 04:26 PM Brophy Gerard EVP, Biopharma Production May 20 Sale 17.36 25,495 442,593 196,583 May 22 04:22 PM Stubblefield Michael CEO Mar 12 Option Exercise 1.60 200,000 320,000 1,375,635 Mar 13 04:32 PM GUPTA RAJIV Director Mar 10 Option Exercise 1.60 143,000 228,800 708,746 Mar 12 04:25 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite